• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性乳腺磁共振筛查的正常实质增强模式。

Normal parenchymal enhancement patterns in women undergoing MR screening of the breast.

机构信息

Department of Radiology, The University of Chicago, 5841 South Maryland Avenue, MC 2026, Chicago, IL 60637, USA.

出版信息

Eur Radiol. 2011 Jul;21(7):1374-82. doi: 10.1007/s00330-011-2080-z. Epub 2011 Feb 17.

DOI:10.1007/s00330-011-2080-z
PMID:21327872
Abstract

OBJECTIVES

To characterize the kinetic and morphological presentation of normal breast tissue on DCE-MRI in a large cohort of asymptomatic women, and to relate these characteristics to breast tissue density.

METHODS

335 consecutive breast MR examinations in 229 asymptomatic women undergoing high-risk screening evaluations based on recommendations from the American Cancer Society including strong family history and genetic predisposition were selected for IRB-approved review (average age 49.2 ± 10.5 years). Breast tissue density was assessed on precontrast T₂-weighted images. Parenchymal enhancement pattern (PEP) was qualitatively classified as minimal, homogeneous, heterogeneous or nodular. Quantitative analysis of parenchymal enhancement kinetics (PEK) was performed, including calculation of initial and peak enhancement percentages (E₁, E(peak)), the time to peak enhancement (T ( peak )) and the signal enhancement ratio (SER).

RESULTS

41.8% of examinations were classified as minimal, 13.7% homogeneous, 23.9% heterogeneous and 21.2% nodular PEP. Women with heterogeneously or extremely dense breasts exhibited a higher proportion of nodular PEP (44.2% (27/61)) and significantly higher E₁, and E(peak) (p < 0.003) compared with those with less dense breasts.

CONCLUSIONS

Qualitative and quantitative parenchymal enhancement characteristics vary by breast tissue density. In future work, the association between image-derived MR features of the normal breast and breast cancer risk should be explored.

摘要

目的

在一个大型无症状女性队列中,描述 DCE-MRI 上正常乳腺组织的动力学和形态学表现,并将这些特征与乳腺组织密度相关联。

方法

选择了 229 名无症状妇女的 335 次连续乳腺磁共振检查,这些妇女是根据美国癌症协会的建议进行高风险筛查评估的,包括强烈的家族史和遗传倾向(平均年龄 49.2±10.5 岁)。在对比前 T₂加权图像上评估乳腺组织密度。实质增强模式(PEP)定性分类为最小、均匀、不均匀或结节状。对实质增强动力学(PEK)进行定量分析,包括计算初始和峰值增强百分比(E₁、E(peak))、达到峰值增强的时间(T(peak))和信号增强比(SER)。

结果

41.8%的检查被分类为最小、13.7%均匀、23.9%不均匀和 21.2%结节状 PEP。乳腺不均匀或致密的妇女中,结节状 PEP 的比例更高(44.2%(27/61)),且 E₁和 E(peak)明显更高(p<0.003),与乳腺密度较低的妇女相比。

结论

乳腺实质的增强特征在定性和定量方面均存在差异。在未来的工作中,应探讨正常乳腺的图像衍生 MRI 特征与乳腺癌风险之间的关系。

相似文献

1
Normal parenchymal enhancement patterns in women undergoing MR screening of the breast.女性乳腺磁共振筛查的正常实质增强模式。
Eur Radiol. 2011 Jul;21(7):1374-82. doi: 10.1007/s00330-011-2080-z. Epub 2011 Feb 17.
2
The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer.哺乳期乳房:正常组织与癌症的对比增强磁共振成像
Radiology. 2005 Nov;237(2):429-36. doi: 10.1148/radiol.2372040837.
3
Parenchymal pattern in women with dense breasts. Variation with age and impact on screening outcomes: observations from a UK screening programme.乳腺致密的女性实质模式。随年龄变化的差异及其对筛查结果的影响:来自英国筛查项目的观察结果。
Eur Radiol. 2018 Nov;28(11):4717-4724. doi: 10.1007/s00330-018-5420-4. Epub 2018 May 28.
4
Background parenchymal enhancement on breast MRI: influence of menstrual cycle and breast composition.乳腺MRI的背景实质强化:月经周期和乳腺组成的影响
J Magn Reson Imaging. 2014 Mar;39(3):526-34. doi: 10.1002/jmri.24185. Epub 2013 Apr 30.
5
Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.正常乳腺实质的乳腺MRI对比增强动力学与乳腺癌的存在相关。
Breast Cancer Res. 2016 Jul 22;18(1):76. doi: 10.1186/s13058-016-0734-0.
6
Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.乳腺磁共振成像中 BI-RADS 3 类病变的特征、恶性率及随访:对磁共振图像解读和管理的影响。
Radiology. 2016 Sep;280(3):707-15. doi: 10.1148/radiol.2016151548. Epub 2016 Apr 18.
7
Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue.健康与癌性乳腺组织中对比增强磁共振成像与扩散加权磁共振成像的比较。
Eur J Radiol. 2015 Oct;84(10):1888-93. doi: 10.1016/j.ejrad.2015.06.023. Epub 2015 Jul 2.
8
Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.动态对比增强磁共振成像(DCE-MRI)中乳腺病变特征性动力学曲线的自动识别与分类
Med Phys. 2006 Aug;33(8):2878-87. doi: 10.1118/1.2210568.
9
Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.芳香酶抑制剂对乳腺磁共振成像中背景实质强化和纤维腺体组织量的影响。
Radiology. 2012 Sep;264(3):670-8. doi: 10.1148/radiol.12112669. Epub 2012 Jul 6.
10
Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.与对比增强乳腺摄影中背景实质增强相关的因素。
AJR Am J Roentgenol. 2021 Feb;216(2):340-348. doi: 10.2214/AJR.19.22353. Epub 2020 Dec 23.

引用本文的文献

1
High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy.对侧乳腺实质高背景强化是接受化疗的三阴性乳腺癌患者预后良好的一种影像生物标志物。
Am J Transl Res. 2021 May 15;13(5):4422-4436. eCollection 2021.
2
Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk.定量测量背景实质增强可预测乳腺癌风险。
AJR Am J Roentgenol. 2021 Jul;217(1):64-75. doi: 10.2214/AJR.20.23804. Epub 2020 Sep 2.
3
Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy.

本文引用的文献

1
Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound.背景增强在乳腺磁共振成像中的应用:与乳腺 X 线摄影中的乳腺密度和超声中的背景回声纹理的相关性。
Eur J Radiol. 2011 Dec;80(3):719-23. doi: 10.1016/j.ejrad.2010.07.019. Epub 2010 Aug 14.
2
Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?乳腺钼靶密度是否为携带 BRCA 突变的女性的乳腺癌危险因素?
J Clin Oncol. 2010 Aug 10;28(23):3779-83. doi: 10.1200/JCO.2009.27.5933. Epub 2010 Jul 12.
3
Breast tissue composition and susceptibility to breast cancer.
新辅助治疗的雌激素受体阳性乳腺癌的乳腺癌成像现状及反应的潜在定量成像标志物
Cancers (Basel). 2020 Jun 9;12(6):1511. doi: 10.3390/cancers12061511.
4
Discrimination between breast invasive ductal carcinomas and benign lesions by optimizing quantitative parameters derived from dynamic contrast-enhanced MRI using a semi-automatic method.利用半自动化方法优化动态对比增强 MRI 定量参数鉴别乳腺浸润性导管癌与良性病变。
Int J Clin Oncol. 2019 Jul;24(7):815-824. doi: 10.1007/s10147-019-01421-1. Epub 2019 Feb 27.
5
Machine learning-based prediction of future breast cancer using algorithmically measured background parenchymal enhancement on high-risk screening MRI.基于机器学习的高危筛查 MRI 算法测量背景实质增强对未来乳腺癌的预测。
J Magn Reson Imaging. 2019 Aug;50(2):456-464. doi: 10.1002/jmri.26636. Epub 2019 Jan 16.
6
A Gradient-Based Approach for Breast DCE-MRI Analysis.基于梯度的乳腺 DCE-MRI 分析方法。
Biomed Res Int. 2018 May 16;2018:9032408. doi: 10.1155/2018/9032408. eCollection 2018.
7
Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.动态对比增强 MRI 在评估 ER 阳性、HER2 阴性、淋巴结阴性浸润性乳腺癌中对侧实质增强与生存结局的相关性中的作用。
J Magn Reson Imaging. 2018 Dec;48(6):1678-1689. doi: 10.1002/jmri.26176. Epub 2018 May 7.
8
Discrimination between malignant and benign mass-like lesions from breast dynamic contrast enhanced MRI: semi-automatic vs. manual analysis of the signal time-intensity curves.基于乳腺动态对比增强磁共振成像鉴别恶性与良性肿块样病变:信号时间-强度曲线的半自动分析与手动分析
J Cancer. 2018 Feb 12;9(5):834-840. doi: 10.7150/jca.23283. eCollection 2018.
9
Evaluation of background parenchymal enhancement on breast MRI: a systematic review.乳腺MRI背景实质强化的评估:一项系统综述
Br J Radiol. 2017 Feb;90(1070):20160542. doi: 10.1259/bjr.20160542. Epub 2016 Dec 7.
10
Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response.新辅助化疗前后乳腺MRI的背景实质强化:与肿瘤反应的相关性
Eur Radiol. 2016 Jun;26(6):1590-6. doi: 10.1007/s00330-015-4011-x. Epub 2015 Sep 17.
乳房组织成分与乳腺癌易感性。
J Natl Cancer Inst. 2010 Aug 18;102(16):1224-37. doi: 10.1093/jnci/djq239. Epub 2010 Jul 8.
4
The BI-RADS breast magnetic resonance imaging lexicon.乳腺影像报告和数据系统(BI-RADS)乳腺磁共振成像术语词典
Magn Reson Imaging Clin N Am. 2010 May;18(2):171-85, vii. doi: 10.1016/j.mric.2010.02.001.
5
Quantitative analysis of breast parenchymal patterns using 3D fibroglandular tissues segmented based on MRI.基于 MRI 分割的三维纤维腺体组织对乳腺实质模式的定量分析。
Med Phys. 2010 Jan;37(1):217-26. doi: 10.1118/1.3271346.
6
Correlation between breast density in mammography and background enhancement in MR mammography.乳腺 X 线摄影中的乳腺密度与磁共振乳腺成像中的背景增强之间的相关性。
Radiol Med. 2010 Apr;115(3):434-41. doi: 10.1007/s11547-010-0513-4. Epub 2010 Jan 15.
7
Diffusion tensor magnetic resonance imaging of the normal breast.正常乳房的弥散张量磁共振成像。
Magn Reson Imaging. 2010 Apr;28(3):320-8. doi: 10.1016/j.mri.2009.10.003. Epub 2010 Jan 12.
8
Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study.评估一种新型基于 MRI 的乳腺密度估计算法在高乳腺癌遗传风险女性队列中的效用:英国 MARIBS 研究。
Breast Cancer Res. 2009;11(6):R80. doi: 10.1186/bcr2447. Epub 2009 Nov 11.
9
Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model.原位导管癌:X射线荧光显微镜检查和动态对比增强磁共振成像显示在鼠模型中肿瘤性乳腺导管内有钆摄取。
Radiology. 2009 Nov;253(2):399-406. doi: 10.1148/radiol.2533082026.
10
Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.恶性病变的动力学曲线在不同的MRI系统中并不一致:需要改进乳腺动态对比增强MRI采集的标准化。
AJR Am J Roentgenol. 2009 Sep;193(3):832-9. doi: 10.2214/AJR.08.2025.